EG19886A - Process for the preparation of new tetrazole derivatives and their use - Google Patents

Process for the preparation of new tetrazole derivatives and their use

Info

Publication number
EG19886A
EG19886A EG5792A EG5792A EG19886A EG 19886 A EG19886 A EG 19886A EG 5792 A EG5792 A EG 5792A EG 5792 A EG5792 A EG 5792A EG 19886 A EG19886 A EG 19886A
Authority
EG
Egypt
Prior art keywords
preparation
tetrazole derivatives
new tetrazole
new
denotes
Prior art date
Application number
EG5792A
Other languages
English (en)
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Application granted granted Critical
Publication of EG19886A publication Critical patent/EG19886A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Reinforced Plastic Materials (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
EG5792A 1991-01-31 1992-01-28 Process for the preparation of new tetrazole derivatives and their use EG19886A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0020991A AT395853B (de) 1991-01-31 1991-01-31 Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
EG19886A true EG19886A (en) 1996-05-31

Family

ID=3484393

Family Applications (1)

Application Number Title Priority Date Filing Date
EG5792A EG19886A (en) 1991-01-31 1992-01-28 Process for the preparation of new tetrazole derivatives and their use

Country Status (27)

Country Link
US (1) US5254574A (no)
EP (1) EP0497121B1 (no)
JP (1) JPH0641099A (no)
KR (1) KR920014802A (no)
CN (1) CN1034662C (no)
AT (2) AT395853B (no)
AU (1) AU642575B2 (no)
CA (1) CA2060387A1 (no)
CZ (1) CZ27592A3 (no)
DE (1) DE59208058D1 (no)
DK (1) DK0497121T3 (no)
EG (1) EG19886A (no)
ES (1) ES2100242T3 (no)
FI (1) FI920349A (no)
GR (1) GR3022686T3 (no)
HU (1) HUT62583A (no)
IE (1) IE914501A1 (no)
IL (1) IL100621A (no)
LT (1) LTIP1518A (no)
LV (1) LV10446B (no)
MY (1) MY106314A (no)
NO (1) NO179837C (no)
NZ (1) NZ241293A (no)
RU (1) RU2078764C1 (no)
SI (1) SI9210026A (no)
YU (1) YU48089B (no)
ZA (1) ZA92155B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255802B (it) * 1992-08-07 1995-11-16 Luso Farmaco Inst Derivati imidazolici ad attivita' a ii antagonista
GB9507203D0 (en) * 1995-04-07 1995-05-31 Smithkline Beecham Plc Novel compounds
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
RS20060125A (en) * 2003-08-27 2008-06-05 Zentiva A.S., A method of removing the triphenylmethane protecting group
US7803940B2 (en) * 2006-11-24 2010-09-28 Takeda Pharmaceutical Company Limited Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
DE102013202306B4 (de) 2013-02-13 2014-12-18 Adidas Ag Sohle für einen Schuh
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
USD776410S1 (en) 2013-04-12 2017-01-17 Adidas Ag Shoe
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
USD783264S1 (en) 2015-09-15 2017-04-11 Adidas Ag Shoe

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860691D1 (en) * 1977-07-12 1981-08-13 Synthelabo 1,2,4-oxadiazol derivatives, their preparation and application in pharmaceutical compositions
US4771051A (en) * 1985-05-17 1988-09-13 A/S Ferrosan 3-substituted-4,5-dihydro-5-oxo imidazoquinazolines, their preparation, and their use in treating benzodiazepin receptor-related ailments
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
DE3627155A1 (de) * 1986-08-11 1988-02-18 Schering Ag Imidazol-derivate
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
ATE134368T1 (de) * 1989-06-30 1996-03-15 Du Pont Substituierte imidazole und ihre verwendung als hemmmstoff fur angiotensin ii

Also Published As

Publication number Publication date
ATA20991A (de) 1992-08-15
FI920349A0 (fi) 1992-01-27
JPH0641099A (ja) 1994-02-15
ZA92155B (en) 1992-10-28
LV10446B (en) 1995-10-20
EP0497121B1 (de) 1997-02-26
HUT62583A (en) 1993-05-28
FI920349A (fi) 1992-08-01
HU9200292D0 (en) 1992-04-28
NZ241293A (en) 1993-04-28
MY106314A (en) 1995-04-29
SI9210026A (en) 1994-09-30
LTIP1518A (en) 1995-06-26
AT395853B (de) 1993-03-25
YU48089B (sh) 1997-01-08
NO179837C (no) 1996-12-27
RU2078764C1 (ru) 1997-05-10
AU642575B2 (en) 1993-10-21
US5254574A (en) 1993-10-19
CA2060387A1 (en) 1992-08-01
NO179837B (no) 1996-09-16
CN1034662C (zh) 1997-04-23
YU2692A (sh) 1994-11-15
CZ27592A3 (en) 1993-03-17
IL100621A0 (en) 1992-09-06
CN1063689A (zh) 1992-08-19
NO920122L (no) 1992-08-03
IL100621A (en) 1996-08-04
GR3022686T3 (en) 1997-05-31
EP0497121A1 (de) 1992-08-05
IE914501A1 (en) 1992-07-29
DE59208058D1 (de) 1997-04-03
DK0497121T3 (da) 1997-05-05
ATE149164T1 (de) 1997-03-15
KR920014802A (ko) 1992-08-25
ES2100242T3 (es) 1997-06-16
LV10446A (lv) 1995-02-20
AU1063492A (en) 1992-08-06
NO920122D0 (no) 1992-01-09

Similar Documents

Publication Publication Date Title
EG19886A (en) Process for the preparation of new tetrazole derivatives and their use
CA2030338A1 (fr) Composition reductrice, pour deformation permanente des cheveux, contenant en tant qu'agent reducteur un amino mercaptoalkylamide ou l'un de ses sels, et son utilisation dans un procede de deformation permanente des cheveux
IT1255729B (it) Derivati di s-triazina come agenti fotostabilizzanti
NZ236605A (en) 2-aminopyrimidine-4-carboxamide derivatives, preparation and pharmaceutical compositions thereof
ZA893651B (en) 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives,their preparation and their application in therapy
PH18186A (en) Isoquinoline derivatives,a process for their preparation pharmaceutical formulations based on these compounds and the use thereof
ES2104509A1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
AU641686B2 (en) Benzanilides
DE3474445D1 (en) 2-(2-hydroxy-4-(substituted) phenyl) piperidines
RO87991A (ro) Procedeu pentru prepararea unor esteri tiazolidinici substituiti ai unor acizi minerali
PT90262A (pt) Processo para a preparacao de novos derivados trienicos com estrutura cromenica
DE3461079D1 (en) Unsaturated compounds, their preparation and use
GB2282810A (en) Process for the preparation of clavulanic acid
ZA828237B (en) A vasodilator compound,process for the preparation thereof and pharmaceutical compositions therefrom
GB2001054A (en) Inhibitors for body fluid proteins
IT1273591B (it) Composti lattonici utili per il trattamento dell'osteoporosi